Patrick Connor Johnson

26PUBLICATIONS
153CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersHaematologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Apr 07, 2026
Beyond age: Frailty-guided care in hematologic malignancies.

Reed Friend, P Connor Johnson, Daphne Campbell

|Feb 11, 2026
Exploratory association of muscle and adipose tissue indices with clinical outcomes in aggressive lymphomas.

Lea Mantz, P Connor Johnson, Matthew Lei

|Jan 27, 2026
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Viktoria Blumenberg, Filippo Birocchi, Angela Shih

|Oct 31, 2025
A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

J Erika Haydu, Robert A Redd, Matthew M Lei

|Oct 29, 2025
Case 31-2025: A 56-Year-Old Man with Left Lower Abdominal Pain and Anemia.

Bruce E Sands, Anuradha S Shenoy-Bhangle, Jacob E Lemieux

Pageof 5

Frequent Collaborators

6 joint publications

Areej El-Jawahri

6 joint publications

Jeffrey A Barnes

5 joint publications

Jeremy S Abramson

4 joint publications

Ashley M Nelson